CAR T-Cell Therapy Market Size, Trends, Growth, and Forecast (2026-2035)

AI Briefing

• – CAR T-cell therapy offers promising results in treating various types of cancer, with ongoing clinical trials exploring its potential for treating other conditions.
• – The market is expected to experience significant growth driven by increasing adoption and advancements in technology, with projected sales reaching $24.8 billion by 2035.
• – Key players in the market include Kite Pharma, Novartis, and Bristol-Myers Squibb, with ongoing research and development efforts focused on improving efficacy and reducing costs.